Search

everythinglearnresearchcommunity

for

Search:↓

Most pregnancies with SLE resulted in intrauterine growth restriction (IUGR).

Mitochondrial dysfunction may contribute to chronic inflammation and immune system issues in Lichen planopilaris.

Certain microRNAs may protect against hair loss in alopecia areata and could be potential treatment targets.

The document concludes that early diagnosis and treatment are crucial for managing rare hair loss disorders and that more research is needed to improve treatment strategies.

CCCA is a scarring hair loss condition mainly in African descent women, possibly caused by genetics and hairstyling, treated with gentle hair care and medications.

Black dots under trichoscopy can appear in different hair and scalp conditions, not just in alopecia areata.

Hair loss in lupus is different from hair loss in alopecia areata and may indicate lupus activity.

Fibrosing alopecia in a pattern distribution is a unique hair loss condition that may respond to antiandrogen therapy.

The document concludes that new methods improve the accuracy of diagnosing scalp alopecia and challenges the old way of classifying it.

Most treatments for Frontal Fibrosing Alopecia are ineffective, but early anti-inflammatory therapy may help and the condition may stabilize over time.

Early and accurate treatment of Lichen Planopilaris is crucial to prevent permanent hair loss in men.

The document concludes that recognizing specific histological features of different nonscarring alopecias is crucial for accurate diagnosis and understanding hair loss progression.

Chemotherapy and radiotherapy can cause skin side effects like rashes, hair loss, and nail changes, which are usually managed with conservative treatments.

Obesity worsens skin health and losing weight can improve skin conditions.

Mesenchymal stem cells help improve wound healing by reducing inflammation and promoting skin cell growth and movement.

Iron deficiency worsens inflammatory skin diseases by disrupting iron balance and increasing inflammation.

Mesenchymal Stem/Stromal Cells (MSCs) help in wound healing and tissue regeneration, but can also contribute to tumor growth. They show promise in treating chronic wounds and certain burns, but their full healing mechanisms and potential challenges need further exploration.

People with alopecia areata have similar retinal structures but thicker choroidal regions compared to those without the condition.

Wound healing is complex and requires more research to enhance treatment methods.

Chemotherapy can cause various skin reactions, with hair loss being the most common, and proper diagnosis and treatment of these reactions are important.

The document concludes that treatments for cicatricial alopecia are not well-supported by evidence, but hair transplantation shows more predictable and satisfactory results.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

Alopecia Areata is an autoimmune disease affecting hair follicles, influenced by genetic and environmental factors, with rodent models being essential for research.

Patients with severe alopecia areata have higher levels of MIF, which decrease after successful treatment.

Long-standing benign tumors can become cancerous, especially in people with weakened immune systems.

Testosterone reduces heart damage and inflammation after injury.

MSC-sEVs may effectively treat chronic non-healing wounds.

Histone modification is key in treating chronic inflammatory skin diseases.

Substance P may play a role in the inflammation seen in keratosis follicularis spinulosa decalvans.

Alarmin cytokines are key in controlling skin immunity and inflammation.